Hiroya Tamai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Longer tocilizumab administration intervals and lower prednisolone doses seemed pivotal for successful tocilizumab withdrawal while maintaining remission in patients with AOSD.

Hiroya tamaiDivision of rheumatologyDepartment of internal medicineKeio university school of medicineInternal medicineKeio university schoolBiologic therapyJuvenile rheumatoid arthritisUvenile raJuvenile idiopathic arthritisGlucocorticoid therapyAttending physician